AP-2α Regulates S-phase and is a Marker for Sensitivity to PI3K-inhibitor Buparlisib in Colon Cancer [RNA-seq]
Ontology highlight
ABSTRACT: AP-2α Regulates S-phase and is a Marker for Sensitivity to PI3K-inhibitor Buparlisib in Colon Cancer [RNA-seq]
PROVIDER: PRJNA648876 | ENA |
REPOSITORIES: ENA
ACCESS DATA